Viewing Study NCT01119859


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-02-09 @ 12:55 PM
Study NCT ID: NCT01119859
Status: COMPLETED
Last Update Posted: 2013-02-11
First Post: 2010-04-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords: